Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Journal of the American College of Cardiology|July 1, 1990
Intravascular ultrasound imaging: in vitro validation and pathologic correlationR A Nishimura, W D Edwards, C A Warnes, et al.
Circulation|April 11, 2001
Intravascular sonotherapy decreases neointimal hyperplasia after stent implantation in swineP J Fitzgerald, A Takagi, M P Moore, et al.
Circulation|December 1, 1994
Cyclosporine impairs release of endothelium-derived relaxing factors in epicardial and resistance coronary arteriesK Sudhir, J S MacGregor, T DeMarco, et al.
Circulation|July 1, 1992
Intravascular ultrasound imaging of coronary arteries. Is three layers the norm?P J Fitzgerald, F G St Goar, A J Connolly, et al.
American Heart Journal|October 20, 1998
The stent decade: 1987 to 1997. Stanford Stent Summit facultyS N Oesterle, R Whitbourn, P J Fitzgerald, et al.
European Heart Journal|January 12, 2002
Predictors and outcomes of stent thrombosis: an intravascular ultrasound registryNeal G Uren, S P Schwarzacher, J A Metz, et al.
Transplantation|October 3, 2000
Sirolimus (rapamycin) halts and reverses progression of allograft vascular disease in non-human primatesT S Ikonen, J F Gummert, M Hayase, et al.
European Heart Journal|August 1, 1993
Dobutamine stress--Doppler echocardiography before and after coronary angioplastyE S el-Said, P M Fioretti, J R Roelandt, et al.
American Heart Journal|June 18, 1998
Enhancement of spatial orientation of intravascular ultrasound images with side holes in guiding cathetersS P Schwarzacher, P J Fitzgerald, J A Metz, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Efficacies of sirolimus (rapamycin) and cyclosporine in allograft vascular disease in non-human primates: trough levels of sirolimus correlate with inhibition of progression of arterial intimal thickeningT S Ikonen, J F Gummert, N Serkova, et al.
Pageof 15